Back

Travelers Companies Earnings Beat Drives Analyst Target Revisions

lite News Desk 2 min read

At a glance

  • Q2 2026 earnings per diluted share reached $10.26.
  • Stock opened at $363.83 on August 24, 2026.
  • Analysts maintained a Hold rating with a $354.26 target.

Travelers Companies reported strong financial results for the second quarter of 2026, which led to changes in analyst price targets and continued attention to the company’s stock performance.

The insurer’s second-quarter earnings per diluted share rose to $10.26, up from $6.53 in the same period the previous year. Core income per diluted share for the quarter was $10.04, with total core income reaching $2.160 billion. The company’s underlying combined ratio for the quarter was 84.1%, while the all-in combined ratio stood at 83.6%.

Travelers Companies also reported net favorable prior-year reserve development totaling $578 million pre-tax for the quarter. Net investment income after tax increased by 14% year-over-year, reaching $883 million in the second quarter. The company declared a quarterly dividend of $1.25 per share, which implies an annualized payout of $5.00 and a yield of about 1.4% based on the prevailing share price.

As of August 24, 2026, the stock opened at $363.83, which was $9.57 above the consensus analyst price target, representing a premium of approximately 2.7%. The stock’s year-to-date performance was just over 25% at that time. Analysts maintained a consensus Hold rating, with an average price target of $354.26.

What the numbers show

  • Q2 2026 earnings per diluted share: $10.26.
  • Net investment income after tax: $883 million, up 14% year-over-year.
  • Stock opened at $363.83 on August 24, 2026, 2.7% above consensus target.
  • Quarterly dividend declared: $1.25 per share, annualized to $5.00.

Following the release of the second-quarter results, several financial institutions updated their price targets for Travelers Companies. Bank of America Securities raised its price target from $283 to $307 while maintaining an Underperform rating. Mizuho increased its target to $343 from $324 and kept a Neutral rating.

Other firms also adjusted their outlooks. Raymond James set a Strong Buy target of $400, while Truist began coverage with a Buy rating and a $395 objective. Piper Sandler reiterated its Overweight rating and set a $389 target, and Citigroup raised its target to $385.

Industry reaction

Bank of America Securities stated that it raised its price target for Travelers Companies after the company’s second-quarter earnings exceeded expectations, but continued to rate the stock as Underperform.

Mizuho announced an increase in its price target and maintained a Neutral rating, while other firms such as Raymond James, Truist, Piper Sandler, and Citigroup set or raised targets ranging from $385 to $400, reflecting updated assessments following the earnings report.

* This article is based on publicly available information at the time of writing.

Sources and further reading

Note: This section is not provided in the feeds.

Related Articles

  1. A statement outlines that Q1 2026 earnings will be released on April 16, 2026, with a review at 9:30 a.m. ET, according to the company.

  2. CooperCompanies reported Q2 2026 revenue of $1.082 billion in a statement. A net loss of $77.9 million was due to a $271.6 million litigation charge.

  3. Rocket Companies will report Q4 and full-year 2025 results on February 26, 2026. Options activity has shown increased volatility, according to reports.

  4. HPE raised its fiscal 2026 EPS guidance to $2.25–$2.45 and projects networking revenue growth of 65–70%, according to company statements.

  5. TJX Companies reported a five-year total shareholder return exceeding 120% and operates over 5,200 stores globally, according to company data.

More on Business

  1. Inspira Enterprise will launch its Australian operations on August 26, 2026, aiming to enhance AI-driven cybersecurity in the region.

  2. A multi-year partnership aims for $1 billion in joint revenue by 2029, focusing on secure AI and cybersecurity, according to reports.

  3. If your Social Security number is exposed, follow steps from the FTC for recovery, including credit freezes and fraud alerts, according to guidelines.

  4. Vertex Pharmaceuticals reported $12 billion in revenue for 2025, a 9% increase, and plans to acquire Crinetics Pharmaceuticals for $10 billion.

  5. The iShares U.S. Pharmaceuticals ETF saw returns of 53.7%-57.3% over the past year, while Invesco's ETF returned 42.5%, according to reports.